Stock market news live: Stocks close lower as coronavirus death toll rises

In This Article:

Global equity markets slumped Monday as fears over the deadly coronavirus flared further. At its lows of the day, the Dow Jones Industrial Average was down 549 points, or 1.9%.

The sell-off kicked off a busy week for potentially market-moving earnings and economic data releases – including U.S. fourth-quarter GDP and a Federal Reserve rate decision – on a volatile note.

Here’s a look at what’s moving markets on Tuesday, January 28.

4:02 p.m. ET: S&P 500 falls 1.57%, biggest single-day drop since Oct. 2 as coronavirus death toll rises

The S&P 500 fell 1.57% Monday in the index’s biggest single-day drop since October 2 as the death toll from coronavirus continues to rise.

Here’s where the major indices were as of 4:02 p.m. ET:

  • S&P 500 (^GSPC): -1.58% or -52.20 points to 3,243.27

  • Dow (^DJI): -1.58% or -459.09 points to 28,530.64

  • Nasdaq (^IXIC): -1.89% or -175.60 points to 9,139.31

  • Crude oil (CL=F): -2.25% or -1.22 to 52.97 a barrel

  • Gold (GC=F): +0.62% or +9.70 to 1,581.60 per ounce

3:17 p.m. ET: New York sues ‘Pharma Bro’ Martin Shkreli for stifling competition

New York Attorney General Letitia James has filed a lawsuit with the FTC against Vyera Pharmaceuticals and two of its former CEOs, including Martin Shkreli for stifling competition to protect drug pricing.

The lawsuit revolves around Vyera’s toxoplasmosis drug Daraprim (pyrimethamine). According to the lawsuit, “Vyera purchased the drug, increased the price, altered its distribution, and engaged in other conduct to delay and impede generic competition.”

“Martin Shkreli and Vyera not only enriched themselves by despicably jacking up the price of this life-saving medication by 4,000 percent in a single day, but held this critical drug hostage from patients and competitors as they illegally sought to maintain their monopoly,” said Attorney General James in the release.

NEW YORK, NY - AUGUST 3: Former Turing Pharmaceuticals CEO Martin Shkreli smiles as he exits the United States Federal courthouse after day four of deliberations in his federal securities fraud trial on August 3, 2017 in New York City. Credit: Dennis Van Tine/MediaPunch/IPX
NEW YORK, NY - AUGUST 3: Former Turing Pharmaceuticals CEO Martin Shkreli smiles as he exits the United States Federal courthouse after day four of deliberations in his federal securities fraud trial on August 3, 2017 in New York City. Credit: Dennis Van Tine/MediaPunch/IPX

3:09 p.m. ET: Boeing lands more than $12 billion in funding as 737 Max woes continue, CBNC reports

Boeing (BA) reportedly secured more funding than it had initially been seeking to help finance its turnaround efforts in the fall-out from its near year-long grounding of its 737 Max aircraft.

The aircraft maker secured more than $12 billion from more than a dozen banks after having sought a loan of $10 billion, CNBC reported Monday, citing unnamed people familiar with the matter.

Boeing is poised to reported quarterly earnings after market open on Wednesday, during which it is expected to detail its costs in compensating customers and suppliers as a result of the aircraft groundings and recent production halt.